INS and Hypoglycemia: When glycemic and blood pressure control is achieved, clinicians should consider de-escalation strategies, including dose reduction or discontinuation of other antihyperglycemic agents (e.g., insulin) and antihypertensives, to mitigate the risks of hypoglycemia and hypotension.